TrialGuide is a consumer-grade, regulatory compliant mobile app and reminder system for patient engagement.
Enabling Electronic Informed Consent for Clinical Research Sites
Watch this information session on electronic informed consent designed exclusively for clinical research si...
Other content in this Stream
Signant Health Joins the Association of Clinical Research Organizations to Add a Technology Perspective on the Future of Clinical Research
As the 13th member company elected into Association of Clinical Research Organizations, Signant Health brings our unique voice and views on patient-centricity and trial technology to the forefront
Simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with ActiGraph integration
The integration of Signant Health’s TrialMax® eCOA platform with ActiGraph’s CentrePoint system and research-grade wearables marries ease-of-use with real-time data and insights
Signant Health's eCOA and Endpoint Quality Solutions for Orphan Disease Research
Signant Health provides a complete eCOA and Endpoint Quality solution that is user-friendly & allows you to capture data on clinician & patient-rated outcome measures & event diaries, on-site or home
Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA
Q&A with Katie Garner, Signant Health: Using eCOA in Ulcerative Colitis Trials for Seamless MAYO Score Calculation
Signant Health Hosts 8th Annual eCOA Forum
Signant Health hosts 8th annual eCOA Forum, Dec 10-11, 2019 in Philadelphia.
Signant Health Sponsors and Presents at CNS Summit 2019
Signant Health Sponsors and Presents at CNS Summit 2019.
Patient-Facing Technologies in Clinical Research: Myths vs. Reality
This webinar explores misconceptions surrounding technologies like eConsent and BYOD ePRO with industry experts, helping you make informed decisions and improve your clinical trial success.
The University of Bristol Selects Signant Health's TrialConsent Solution in Oncology Trial
The Prestigious UK Academic Institution selected TrialConsent® to Administer eConsent to Benefit Sites and Patients in Future Clinical Research.
Get to Know TrialMax eCOA - Signant Health
When it comes to eCOA – the patient experience matters. Watch this video to learn more about TrialMax.
Signant Health Sponsors Rare Disease Film Festival
Signant Health is proud to sponsor Disorder: The Rare Disease Film Festival (RDFF).
Signant Selected as eConsent Provider by Shanghai Mental Health Center
Signant Health has been selected to provide eConsent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC).
Bill Byrom Welcomes You to the 2019 eCOA Forum
Bill Byrom welcomes you to the 2019 eCOA Forum. Join us Dec 10-11, 2019 in Philadelphia.
Signant Health's Endpoint Quality Solution
Signant Health’s Endpoint Quality solution offers a comprehensive array of evidence-based services to ensure the accuracy and precision of clinical trial endpoint data across a variety of therapeutic
Clinical Trial Supply East Asia, Dec 11-12, 2019, Seoul, Korea
In December, we will be attending CTS East Asia and we want to talk to you and see how we can aid in making your clinical trials easier.
Signant Health Appoints Todd Everhart as Clinical Vice President
Signant Health has appointed Anthony Todd Everhart, MD, FACP to the Signant Health Science and Medicine Team as Clinical Vice President, Internal Medicine.
Signant Health Launches CRO Partner Program
The Signant Health Partner Program enables CROs to better serve sponsors in the areas of Patient Data, Patient Experience, Clinical Supplies, and Endpoint Quality Solutions.
DIA 2019: PharmaVOICE Interview with Mike Nolte, CEO, Signant Health
DIA 2019: PharmaVOICE interview with Mike Nolte, CEO Signant Health.
Signant Health Partner Program
Become a CRO partner today. Sponsors what to know what your competitive edge is, so let's show them. We'll make sure you are distinguished and trusted for delivering across the Signant portfolio.
SmartSupplies Forecasting & Planning product overview
Signant Health's Dr. David Daniel Honored in 2019 PharmaVoice 100